Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.10M | -67.76M | -62.10M | -52.40M | -47.25M |
| Total Depreciation and Amortization | 39.00K | 28.00K | 18.00K | 9.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.65M | 22.77M | 22.69M | 22.01M | 20.60M |
| Change in Net Operating Assets | -949.00K | 1.39M | 5.24M | 2.31M | 5.34M |
| Cash from Operations | -53.36M | -43.57M | -34.16M | -28.08M | -21.31M |
| Capital Expenditure | -141.00K | -122.00K | -117.00K | -75.00K | -30.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -5.00M | -5.00M |
| Cash from Investing | -141.00K | -122.00K | -117.00K | -5.08M | -5.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 5.39M | 10.92M | 73.34M | 67.96M | 67.96M |
| Repurchase of Common Stock | -352.00K | -352.00K | -318.00K | -318.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -736.00K | -826.00K | 42.00M | 42.20M | 42.74M |
| Cash from Financing | 4.30M | 9.74M | 115.03M | 109.84M | 110.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.20M | -33.95M | 80.75M | 76.69M | 84.36M |